IL10 and familial pancreatic carcinoma: As we can see, plasma IL-10 concentrations was significantly increased in pancreatic cancer patients (median = 2.45 pg/mL, n = 34), with comparison to both benign pancreatic disease patients (median = 1.99 pg/mL, n = 15, P = 0.047), and normal donors (median = 1.10 pg/mL, n = 13, p<0.001).